Showing results (291-300 of 641) with videos related to
Sort By:
Pageof 65
Journal of Vascular Surgery|September 22, 2014
Open repair versus fenestrated endovascular aneurysm repair of juxtarenal aneurysmsRohini Rao, Tristan R A Lane, Ian J Franklin, et al.Human Molecular Genetics|December 15, 2022
Upregulation of non-canonical and canonical inflammasome genes associates with pathological features in Krabbe disease and related disordersMaría B Cachón-González, Chao Zhao, Robin J Franklin, et al.Oral Surgery, Oral Medicine, and Oral Pathology|February 1, 1988
The effect of collagen and indomethacin on inflamed dental pulp wounds of baboon teethB R Oguntebi, M S Dover, C J Franklin, et al.Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 9, 1999
Establishing the etiology of childhood hearing lossL A Ohlms, A Y Chen, M G Stewart, et al.JAMA Health Forum|February 9, 2024
Acute Diabetes Complications After Transition to a Value-Based Medication BenefitJ Franklin Wharam, Stephanie Argetsinger, Matthew Lakoma, et al.Lasers in Medical Science|October 5, 2013
Socio-economic impact of endovenous thermal ablation techniquesDamian Kelleher, Tristan R A Lane, Ian J Franklin, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 25, 2000
Is the international prognostic score for advanced stage Hodgkin's disease applicable to early stage patients? German Hodgkin Lymphoma Study GroupJ Franklin, U Paulus, D Lieberz, et al.Inorganic Chemistry|January 3, 1996
Kinetics of the Formation of Macrocyclic Polyaminocarboxylate Ligand Complexes: A Laser-Excited Luminescence Study of the Eu(3+)-dtpa-dien SystemShu Ling Wu, Sonya J. Franklin, Kenneth N. Raymond, et al.Journal of Medicinal Chemistry|July 10, 1992
Novel inhibitors of prolyl 4-hydroxylase. 3. Inhibition by the substrate analogue N-oxaloglycine and its derivativesC J Cunliffe, T J Franklin, N J Hales, et al.Phlebology|February 8, 2012
Treatment options, clinical outcome (quality of life) and cost benefit (quality-adjusted life year) in varicose vein treatmentD Kelleher, T R A Lane, I J Franklin, et al.Pageof 65